Orphan diseases are diseases which affect a small number of people compared to the general population and specific issues are raised in relation to their rarity. Thanks to the development of diagnostic methods, doctors identify more and more patients with such diseases. This raises the question of the development and delivery of new drugs. Buying, storing and transporting drugs for treating orphan diseases require specialist expertise. At COREX Logistics we have in-depth knowledge relating to the purchase and supply of orphan drugs.
Stages of kits preparation:
Importation of drugs under MAP / NPP programs
At COREX Logistics we have extensive experience in managing all aspects of the importation of unregistered drugs for compassionate use/vital indications under programs including MAP, EAP and NPP.
Storage and temperature logistics
Orphan drugs are often extremely expensive and so we take the utmost care in handling them to ensure their safety and efficacy.
Purchase of orphan drugs for clinical trials
We carry out all basic and additional procedures and approvals with drug manufacturers.
We work with Clinical Trial Organisations and Healthcare Providers to access and supply potentially life-changing medicines and treatments, and provide practical care and supporting patients and families with tailored solutions.
We procure and deliver as-yet domestically unapproved or unavailable drugs and treatments directly to patients with a serious diagnosis. We handle all customs and regulatory paperwork, and provide additional supports throughout treatment.